Atractylenolide II combined with Interferon-γ synergistically ameliorates colorectal cancer progression <i>in vivo</i> and <i>in vitro</i> by blocking the NF-kB p65/PD-L1 pathway. This evidence concerns the gene NFKB1 and colorectal cancer.